Method for screening human intestinal Npt2B modulatory agents
AssigneeRoche Palo Alto LLC
InventorsPaul David Cannon, Suryanarayana Sankuratri
Life of this patent
Estimating the term…
Abstract
A novel human sodium phosphate cotransporter expressed on the apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto, as well as nucleic acid compositions encoding the same, are provided. The subject polypeptides and nucleic acid compositions find use in a variety of applications, including research, diagnostic, and therapeutic agent screening applications. Also provided are methods of inhibiting Npt2B activity in a host and methods of treating disease conditions associated with Npt2B activity.
Claims3
A method of screening to identify Npt2B modulatory agents, said method comprising:
- contacting a cell expressing a functional Npt2B polypeptide on its surface, said polypeptide comprising the amino acid sequence set forth in SEQ ID NO:1 on its surface with a candidate agent in the presence of phosphorous anion;
- and determining the amount of phosphorous anion uptake by said cell wherein an altered uptake in the amount of phosphorous agent in the presence of a candidate agent identifies an Npt2B modulatory agent.
Dependencies are inferred from the claim text.